Astria Ascending takes place in the land of Harmonia, which has eight demi-gods protecting its five cities. We meet these heroes in the middle of a new crisis plaguing the land that involves invading ...

Astria Health filed May 6, for Chapter 11 bankruptcy protection. Given that Astria operates three hospitals and a network of clinics in the Yakima Valley, that means you probably have questions. We’ll ...

Astria Ascending, a gorgeous fantasy Japanese role-playing game from Artisan Studios, was announced Friday during the ID@Xbox showcase. The beautifully drawn game with turn-based combat is scheduled ...

Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astria's stockholders held on January 21, 2026, Astria's stockholders voted to approve the acquisition of Astria ...

Dear Villagers will release the newly announced, Artisan Studios-developed RPG Astria Ascending for PlayStation 5, Xbox Series, PlayStation 4, Xbox One, Switch, and PC via Steam and the Epic Games ...

Astria Health’s efforts to emerge from Chapter 11 bankruptcy protection likely will continue well into the first quarter of 2020, and might include selling some assets. If the U.S. Bankruptcy Court ...

Astria, a blockchain project describing itself as the "first decentralized shared sequencing layer," has launched the main network for its alpha release. The project is among those aiming to ...

A Sunnyside, Washington-based health system is laying the blame for its 2019 bankruptcy squarely on the shoulders of its EHR vendor — Cerner. In a lawsuit filed last week, Astria Health claims that ...

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for ...

-- Kaken Pharmaceutical, Co., Ltd. Will Pay Astria Therapeutics Up to $32 Million in Upfront and Milestone Payments, Plus Royalties for Japanese Development and Commercialization Rights Related to ...

Astria Therapeutics, Inc. (ATXS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock ...